←
Johnny Lee, MD257 posts
Johnny Lee, MD avatar

Johnny Lee, MD

@johnnyleebio

Dabbles in informatics. Tea, not coffee. 🍵

◷ Joined September 2017▧ 13 Photos and videos
Naomi Handly avatar
⟳ Johnny Lee, MD retweeted
Naomi Handly@lnhandly·Aug 15

One of the unexpected benefits of @OctantBio OA program is that the OAs keep coming back ❤️ @johnnyleebio was in our first class of OAs, built OCTOPUSv1, and is now a 3rd yr resident doing incredible things for patients. He’s even done some consulting work!

Post attachment
Radiology of USC avatar
⟳ Johnny Lee, MD retweeted
Radiology of USC@RadiologyUSC·21 Mar 2025

It's #MatchDay2025!! 👀 Check out these stars! 🤩 Thrilled to have matched with this talented bunch, looking forward to 2026/27! Welcome to the Trojan and LAG families! 🙌

Post attachment
Sri Kosuri avatar
⟳ Johnny Lee, MD retweeted
Sri Kosuri@srikosuri·8 Feb 2025

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases. I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known. People can contact me directly at my first name (as written in my profile) at octant.bio.

Post attachment
Patrick Hsu avatar
⟳ Johnny Lee, MD retweeted
Patrick Hsu@pdhsu·14 Nov 2024

Today we report Evo, a generalist foundation model for biology, on the cover of @ScienceMagazine. Trained on billions of DNA nucleotides, Evo was designed to capture two key aspects of biology: the multi-modality of the central dogma and the multi-scale nature of evolution.

A new Science study presents “Evo”—a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from molecular to genome scale, with unparalleled accuracy. Evo’s ability to predict, generate, and engineer entire genomic sequences could change the way synthetic biology is done. Learn more in this week's issue: bit.ly/3OsmUPr

Post attachment
Sri Kosuri avatar
⟳ Johnny Lee, MD retweeted
Sri Kosuri@srikosuri·13 Nov 2024

Excited to join @Ginkgo's Board of Directors. I've watched Ginkgo start out of MIT in 2008 and followed their journey closely over the years. I'm excited to work with @jrkelly @reshmapshetty and the rest of the team to make biology easier to engineer in the coming years.

Sri Kosuri avatar
⟳ Johnny Lee, MD retweeted
Sri Kosuri@srikosuri·31 Aug 2024

We've started IND-enabling studies on a small molecule corrector for Rho-associated autosomal dominant retinitis pigmentosa (Rho-adRP). I thought it would be fun to spend some time walking through our approach and why we are excited. Long 🧵1/

Sri Kosuri avatar
⟳ Johnny Lee, MD retweeted
Sri Kosuri@srikosuri·8 Jun 2024

Octant 7th birthday party tonight. It’s been such a privilege to build with this crew over so long. ❤️

Post attachment
Johnny Lee, MD avatar
Johnny Lee, MD@johnnyleebio·15 Feb 2024

Fantastic to be back @OctantBio. I’ve learned so much from this team since college, and I’m excited to be working on the clinical development of our corrector therapies. Check out what the Octonauts have been up to at octant.bio/pipeline

We're thrilled to welcome back @johnnyleebio, an original Octant Apprentice. Completing his medical degree at USC, he's now teaming up with us to push our rare disease programs to clinical development. For more details on our programs, see here! octant.bio/pipeline

Post attachment
Sri Kosuri avatar
⟳ Johnny Lee, MD retweeted
Sri Kosuri@srikosuri·29 Oct 2023

It was really fun to have @jasonjoyride come by @OctantBio and spend some time with us to hear about what we are doing on an early Saturday morning.

What does synthetic biology, chemistry, robotics, and AI have in common? They're all being used by @OctantBio to discover new drugs for previously untreatable diseases. Episode 15 of S³ dives deep into the new and cutting edge world of drug discovery.

9:24